Cannabidiol reduces short- and long-term high glutamate release after severe traumatic brain injury and improves functional recovery

HIGHLIGHTS

• who: Cindy Santiago-Castañeda and colleagues from the Department of Pharmacobiology, Center for Research and Advanced Studies (CINVESTAV) have published the Article: Cannabidiol Reduces Short- and Long-Term High Glutamate Release after Severe Traumatic Brain Injury and Improves Functional Recovery, in the Journal: Pharmaceutics 2022, 1609 of 14/06/2022
• what: The short-term experiment focused on identifying the optimal oral pretreatment of CBD. This study aimed to determine whether oral pretreatment with CBD prevents high glutamate concentration in the cortex and reduces short- and long-term sensorimotor impairment, body weight loss, and mortality . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.